and Lung Transplantation – into the fourth decade, from strength to strength. J Heart
Lung Transplant 2013;32:941–50.
2. Barnard CN. The operation. A human cardiac transplant: an interim report of a successful
operation per- formed at Groote Schuur Hospital, Cape Town. S Afr Med J
1967;41:1271–4.
3. Dipchand AI, Kirk R, Edwards LB, et al. The Registry of the International Society for Heart
and Lung Transplantation: sixteenth official pediatric heart transplantation report –
2013; focus theme: age. J Heart Lung Transplant 2013;32:979–88.
4. Canter CE, Shaddy RE, Bernstein B, et al. Indications for heart transplantation in pediatric
heart disease: a scientific statement from the American Heart Association Council on
Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular
Nursing, and Cardio- vascular Surgery and Anesthesia; and the Quality of Care and
Outcomes Research Interdisciplinary Working Group. Circulation 2007;115:658–76.
5. Kirklin JK, Naftel DC, Caldwell RL, et al. Should status II patients be removed from the
pediatric heart transplant waiting list? A multi-institutional study. J Heart Lung
Transplant 2006;25:271–5.
6. Fricker FJ, Addonizio L, Bernstein D, et al. Heart transplantation in children: indications.
Pediatr Transplant 1999;3:333–42.
7. Jenkins PC, Flanagan MF, Sargent JD, et al. A comparison of treatment strategies for
hypoplastic left heart syndrome using decision analysis. J Am Coll Cardiol
2001;38:1181–7.
8. Shaddy RE, Parisi F. Pediatric heart transplantation. In: Allen HD, Driscoll DJ, Shaddy RE,
Feltes TF (eds) Moss and Adams’ Heart Disease in Infants, Children, and Adolescents
Including the Fetus and Young Adult, 8th edn. Philadelphia: Lippincott, Williams &
Wilkins, 2013 pp. 1384–400. 9. Davies RR, Russo MJ, Mital S, et al. Predicting survival among high-risk pediatric cardiac
transplant recipients: an analysis of the United Network for Organ Sharing database. J
Thorac Cardiovasc Surg 2008;135:147–55.
10. Kimberling MT, Balzer DT, Hirsch R, et al. Cardiac transplantation for pediatric
restrictive cardiomyopathy: presentation, evaluation and short-term outcome. J Heart
Lung Transplant 2002;21:455–9.
11. Pollock-BarZiv SM, den Hollander N, Ngan BY, et al. Pediatric heart transplantation in
human leukocyte antigen sensitized patients: evolving management and assessment of
intermediate-term outcomes in a high-risk population. Circulation 2007;116:I172–8.
12. Holt DB, Lublin DM, Phelan DL, et al. Mortality and morbidity in pre-sensitized pediatric
heart transplant recipients with a positive donor crossmatch utilizing peri-operative
plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007;26:876–82.
13. Feingold B, Bowman P, Zeevi A, et al. Survival in al- losensitized children after listing for
cardiac transplantation. J Heart Lung Transplant 2007;26:565–71.
14. Stastny P, Lavingia B, Fixler DE, et al. Antibodies against donor human leukocyte
antigens and the outcome of cardiac allografts in adults and children. Transplantation
2007;84:738–45.
15. Wright EJ, Fiser WP, Edens RE, et al. Cardiac trans- plant outcomes in pediatric patients
with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective
crossmatch. J Heart Lung Transplant 2007;26:1163–9.
16. West LJ, Pollock-Barziv SM, et al. ABO-incompatible heart transplantation in infants. N
Engl J Med 2001;344:793–800.
17. Henderson HT, Canter CE, Mahle WT, et al. ABO-incompatible heart transplantation:
analysis of the Pediatric Heart Transplant Study (PHTS) database. J Heart Lung
Transplant 2012;31:173–9.
18. Urschel S, Larsen IM, Kirk R, et al. ABO-incompatible heart transplantation in early
childhood: an international multicenter study of clinical experiences and limits. J Heart Lung Transplant 2013;32:285–92.
19. Morrow WR. Cardiomyopathy and heart transplantation in children. Curr Opin Cardiol
2000;15:216–23.
20. Mital S, Addonizio LJ, Lamour JM, et al. Outcome of children with end-stage congenital
heart disease waiting for cardiac transplantation. J Heart Lung Transplant 2003;22:147–
53.
21. Gajarski RJ, Mosca RS, Ohye RG, et al. Use of extracorporeal life support as a bridge to
pediatric cardiac transplantation. J Heart Lung Transplant 2003;22:28–34.
22. Morrissey PE, Monaco AP. Donation after circulatory death: current practices, ongoing
challenges, and potential improvements. Transplantation 2014;97:258–64.
23. Gries CJ, White DB, Truog RD, et al. An official American Thoracic Society/International
Society for Heart and Lung Transplantation/Society of Critical Care
Medicine/Association of Organ and Procurement Organizations/United Network of
Organ Sharing Statement: ethical and policy considerations in organ donation after
circulatory determination of death. Am J Respir Crit Care Med 2013;188:103–9.
24. Harrison CH, Laussen PC. Controversy and consensus on pediatric donation after cardiac
death: ethical issues and institutional process. Transplant Proc 2008; 40: 1044–7.
25. Ford MA, Almond CS, Gauvreau K, et al. Association of graft ischemic time with survival
after heart transplant among children in the United States. J Heart Lung Transplant
2011;30:1244–9.
26. Sarti A. Organ donation. Paediatr Anaesth 1999;9:287–94.
27. Ullah S, Zabala L, Watkins B, et al. Cardiac donor organ management. Perfusion
2006;21:93–8.
28. Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the canine heart.
Surg Forum 1960;11:18–25. 29. Khonari S, Sintek CF, Ardehali A. Cardiac surgery: safeguards and pitfalls in operative
technique. Philadelphia, PA: Lippincott Williams & Wilkins, 2008, p. 190.
30. Schnoor M, Schäfer T, Lü hmann D, et al. Bicaval versus standard technique in orthotopic
heart transplantation: a systematic review and meta-analysis. J Thorac Cardiovasc Surg
2007;134:1322–31.
31. Weiss ES, Nwakanma LU, Russell SB, et al. Outcomes in bicaval versus biatrial techniques
in heart transplantation: an analysis of the UNOS database J Heart Lung Transplant
2008;27:178–83.
32. Rivenes SM, Lewin MB, Stayer SA, et al. Cardiovascular effects of sevoflurane, isoflurane,
halothane, and fentanyl–midazolam in children with congenital heart disease: an
echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology
2001;94:223–9.
33. Schure AY, Kussman BD. Pediatric heart transplantation: demographics, outcomes, and
anesthetic implications. Paediatr Anaesth 2011;21:594–603.
34. Schumacher KR, Gajarski RJ. Postoperative care of the transplanted patient. Curr Cardiol
Rev 2011;7:110–22.
35. Sawasdiwipachai P, Laussen PC, McGowan FX, et al. Cardiac arrest after neuromuscular
blockade reversal in a heart transplant infant. Anesthesiology 2007;107:663–5.
36. Backman SB (2008) Anticholinesterase drugs and the transplanted heart.
Anesthesiology 2008;108:965.
37. Lin C, Chan K, Chou Y, et al. Transesophageal echocardiography monitoring of
pulmonary venous struction induced by sternotomy closure during infant heart
transplantation. Br J Anaesth 2002;88:590–952.
38. Dietl W, Bauer M, Podesser BK. Nitric oxide in cardiac transplantation. Pharmacol Rep
2006;58 145–152. 39. Mitchell MB, Campbell DN, Bielefeld MR, et al. Utility of extracorporeal membrane
oxygenation for early graft failure following heart transplantation in infancy. J Heart
Lung Transplant 2000;19:834–839.
40. Ibrahim JE, Sweet SC, Flippin M, et al. Rejection is reduced in thoracic organ recipients
when transplanted in the first year of life. J Heart Lung Transplant 2002;21:311– 318.
41. Rochea SL, Burch M, O’Sullivana J, et al. Multicenter experience of ABO-incompatible
pediatric cardiac trans- plantation. Am J Transplant 2008;8:208–215.
42. Reddy SC, Laughlin K, Webber SA, et al. Immunosuppression in pediatric heart
transplantation: 2003 and beyond. Curr Treat Options Cardiovasc Med 2003;5:417–428.
43. Chan M, Pearson GJ. New advances in antirejection therapy. Curr Opin Cardiol
2007;22:117–122.
44. Patel JK, Kobashigawa JA. Tacrolimus in heart transplant patients: an overview. Biodrugs
2007;21:139–143.
45. Zuckermann A, Manito N, Epailly E, et al. Multidisciplinary insights on clinical guidance
for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung
Transplant 2008;27:141–149.
46. Pahl E. Statins in the prevention of transplant coronary artery disease: in pediatric heart
recipients. Pediatr Transplantation 2007;11:459–460.
47. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for
the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung
Transplant 2005;24:1710–1720.
48. Law YM. Pathophysiology and diagnosis of allograft rejection in pediatric heart
transplantation. Curr Opin Cardiol 2007;22:66–71.
49. Leonard GTJr, Fricker FJ, Pruett D, et al. Increased, myocardial performance index
correlates with biopsy- proven rejection in pediatric heart transplant recipients. J Heart
Lung Transplant 2006;25:61–66.
50. Behera SK, Trang J, Feeley BT, et al. The use of Doppler tissue imaging to predict cellular and antibody-mediated re- jection in pediatric heart transplant recipients. Pediatr
Transplant 2008;12:207–214.
51. Mondillo S, Maccherini M, Galderisi M. Usefulness and limitations of transthoracic
echocardiography in heart transplantation recipients. Cardiovasc Ultrasound 2008;6:2.
52. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation
2008;117:2131–2141.
53. Maiers J, Roger Hurwitz R. Identification of coronary artery disease in the pediatric
cardiac transplant patient. Pediatr Cardiol 2008;29:19–23.
54. Labarrere CA, Nelson DR, Park JW. Pathologic markers of allograft arteriopathy: insight
into the pathophysiology of cardiac allograft chronic rejection. Curr Opin Cardiol
2001;16:110–117.
55. Schowengerdt KO, Naftel DC, Seib PM, et al. Infections after pediatric heart
transplantation: results from a multi-institutional study. J Heart Lung Transplant
1997;16:1207–1216.
56. Kulikowska A, Boslaugh SE, Huddleston CB, et al. Infectious, malignant, and autoimmune
complications in pediatric heart transplant recipients. J Pediatr 2008;152:671– 6777.
57. Lee CK, Christensen LL, Magee JC, et al. Pre- transplant risk factors for chronic renal
dysfunction after pediatric heart transplantation: a 10-year national cohort study. J
Heart Lung Transplant 2007;26:458–465.
58. Rakhit A, Nurko S, Gauvreau K, et al. Gastrointestinal complications after pediatric
cardiac transplantation. J Heart Lung Transplant 2002;21:751–759.
59. Davis JA, McBride MG, Chrisant MR, et al. Longitudinal assessment of cardiovascular
exercise performance after pediatric heart transplantation. J Heart Lung Transplant
2006;25:626–633
60. Abarbanell G, Mulla N, Chinnock R, et al. Exercise assessment in infants after cardiac
transplantation. J Heart Lung Transplant 2004;23:1334–1338.
61. Todaro JF, Fennell EB, Sears SF, et al. Review: cognitive and psychological outcomes in pediatric heart transplantation. J Pediatr Psychol 2000;25:567–576.
62. Simons LE, Anglin G, Warshaw BL, et al. Understanding the pathway between the
transplant experience and health-related quality of life outcomes in adolescents. Pediatr
Transplant 2008;12:187–193.
63. Young GS, Mintzer LL, Seacord D, et al. Symptoms of posttraumatic stress disorder in
parents of transplant recipients: incidence, severity, and related factors. Pediatrics
2003;111:725–731.
64. Wernovsky G, Newburger J. Neurologic and develop- mental morbidity in children with
complex congenital heart disease. J Pediatr 2003;142:6–8.
65. Khagani A, Santini F, Dyke CM, et al. Heterotopic car- diac transplantation in infants and
children. J Thorac Cardiovasc Surg 1997;113:1042–1049.
66. Astora TL, Galantowicz M, Phillips A, et al. Domino heart transplantation involving
infants. Am J Transplant 2007;7:2626–2629.
67. Manzoni D, D’Ercole C, Spotti A, et al. Congenital heart disease and pediatric liver
transplantation: complications and outcome. Pediatr Transplant 2007;11:876–881.
68. Asrani SK, Asrani NS, Freese DK, et al. Congenital heart disease and the liver. Hepatology
2012;56:1160–9.
69. Camposilvan S, Milanesi O, Stellin G, et al. Liver and cardiac function in the long term
after Fontan operation. Ann Thorac Surg 2008;86:177–182.
70. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or
transplantation in patients after Fontan surgery. Heart 2013;99:491–6.
71. Concejero A, Chen CL, Liang CD, et al. Atrial septal defect in end-stage liver disease
children before and after liver transplantation. Surgery 2008;143:271–277.
72. Krowka MJ, Miller DP, Barst RJ, et al. Portopulmonary hypertension: a report from the
US-based REVEAL Registry. Chest 2012;141:906–15. 73. Feier FH, Neto JS, Porta G, et al. Liver transplantation after stage II palliation for
hypoplastic left heart syndrome. Liver Transpl 2013;19:322–7.
74. Cannon RM, Hughes MG, Jones CM, et al.. A review of the United States experience with
combined heart-liver transplantation. Transpl Int 2012;25:1223–8.
75. Khan MS, Heinle JS. Pediatric thoracic multiorgan transplantation. Tex Heart Inst J
2012;39:850–1.
76. Hollander SA, Reinhartz O, Maeda K, et al. Intermediate-term outcomes after combined
heart-liver transplantation in children with a univentricular heart. J Heart Lung
Transplant 2013;32:368–70.
77. Hennessey T, Backman SB, Cecere R, et al. Combined heart and liver transplantation on
cardiopulmonary bypass: report of four cases. Can J Anaesth 2010;57:355–60.
78. Rauchfuss F, Breuer M, Dittmar Y, et al. Implantation of the liver during reperfusion of
the heart in combined heart-liver transplantation: own experience and review of the
literature. Transplant Proc 2011;43:2707–13.
79. Hill AL, Maeda K, Bonham CA, Concepcion W. Pediatric combined heart-liver
transplantation performed en bloc: a single-center experience. Pediatr Transplant
2012;16:392–7.
80. Giakoustidis A, Cherian TP, Antoniadis N, Giakoustidis D. Combined cardiac surgery and
liver transplantation: three decades of worldwide results. J Gastrointestin Liver Dis
2011;20:415–21.
81. Porrett PM, Desai SS, Timmins KJ, et al. Combined orthotopic heart and liver
transplantation: the need for exception status listing. Liver Transpl 2004;10:1539–1544.
82. Topilsky Y, Raichlin E, Hasin T, et al. Combined heart and liver transplant attenuates
cardiac allograft vasculopathy compared with isolated heart transplantation.
Transplantation 2013 27;95:859–65.
83. Johnson MR, Aaronson KD, Canter CF, et al. Heart retransplantation. Am J Transplant 2007;7:2075–2081.
84. Clark JB, Pauliks LB, Myers JL, Undar A. Mechanical circulatory support for end-stage
heart failure in repaired and palliated congenital heart disease. Curr Cardiol Rev
2011;7:102–9.
85. Matsa E, Sallam K, Wu JC. Cardiac stem cell biology: glimpse of the past, present, and
future. Circ Res 2014;114:21–7.
86. Hirt MN, Hansen A, Eschenhagen T. Cardiac tissue engineering: state of the art. Circ Res
2014 ;114:354–67.
87. Lee AY, Mahler N, Best C, et al Regenerative implants for cardiovascular tissue
engineering. Transl Res 2014;163:321–341.
88. Manji RA, Ekser B, Menkis AH, Cooper DK. Bioprosthetic heart valves of the future.
Xenotransplantation 2014 ;21:1–10Jan 21. doi: 10.1111/xen.12080. [Epub ahead of
print].
89. Conway J, Manlhiot C, Kirk R, et al. Mortality and morbidity after retransplantation after
primary heart transplant in childhood: an analysis from the registry of the International
Society for Heart and Lung Transplantation. J Heart Lung Transplant 2014;33:241–51.
90. Lala A, Joyce E, Groarke JD, Mehra MR. Challenges in long-term mechanical circulatory
support and biological replacement of the failing heart. Circ J 2014;78:288–99.
91. Brenden C Registry for the International Society for Heart and Lung transplantation:
Sixteenth Official Pediatric Lung and Heart/Lung Transplantation Report –2013. J Heart
Lung Transplant 2013; 32: 989–997.
92. Conrad C and Cornfield DN: Pediatric lung transplantation: promise being realized 2014:
Curr Opin Pediatr 2014, ;26: 1–9.
93. Corris PA: Lung transplantation for cystic fibrosis and bronchiectasis. Sem Respir Crit
Care Med 2013; 34: 297–304. 94. Aurora P, Carby M and Sweet S: Selection of cystic fibrosis patients for lung
transplantation. Curr Opin in Pul Med 2008,;14:589–594.
95. Elizur A, Sweet S, Huddleston CB et al:et al. Pre-transplant mechanical ventilation
increases short-term morbidity and mortality in pediatric patients with cystic fibrosis. J
Heart Lung Transplant 2007; 26:17–31.
96. Egan TM, Murray S, Bustami RT et al:et al. Development of the new lung allocation
system. Am J Transplant 2006; 6:1212–1227.
97.Munshi, L, Keshavjee S and Cypel M: Donor management and lung preservation for lung
transplantation. The Lancet Resp Med 2013;1:314–328.
98.Botha P, Rostron AJ, Fisher AJ et al:et al. Current strategies in donor selection and
management. Semin Thorac Cardiovasc Surg 2008; 20: 143–51.
99. Steen S, Ingemansson R, Eriksson et al:et al. First human transplantation of non
acceptable donor lung after reconditioning ex vivo. An Thorac Surg 2007; 83:2191–94.
100. Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S.: Ex-vivo lung perfusion. Transpl
Int 2014 Mar 15. doi: 10.1111/tri.12317.
101. Hoganson DM, Gazit AZ, Boson, US, Sweet SC, Grady RM, Huddlestom CB and Eghtesady
PE. Paracorporeal lung assist devices as a bridge to recovery ot lung transplantation in
neonates and young children. J Thorac Cardiovasc Surg 2014.; 147(1): 420–427.
102. Huddleston CB, Sweet SC, Mallory GB et al:et al. Lung transplant in very young infants. J
Thorac and Cardiovasc Surg 1999;118: 796–804.
103. Christie JD, Carby M, Bag R et al:et al. Report of the ISHLT working group on primary
lung graft dysfunction part II: definition. A consensus statement of the International
Society of Heart and Lung Transplanation. J Heart Lung Transplant 2005; 24:1454–59.
104. Suzuki Y, Cantu E and Christie J: Primary Graft Dysfunction. Semin Respir Crit Care Med
2013;34:305–319.
105. Carter YM, Yvette M, Gelman AE, Andrew E. and Kreisel, Daniel:. Pathogenesis, management and consequences of primary graft dysfunction. Semin Thorac Cardiovasc
Surg 2008; 20: 165–172.
106. Meyers BF, de la Morene M, Sweet S et al:et al. Primary graft dysfunction and other
selected complications of lung transplantation: a single center experience of 983
patients. J Heart Lung Transplant 2005; ;129: 1421–29.
107. Daud SA, Yusen RD, Meyers BF et al: . Impact of immediate primary lung allograft
dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med
2007; ;175: :507–13.
108. Kimoff JR, Cheong TH, Cosio MG et al:et al. Pulmonary denervation in humans-
effects on dyspnea and ventilatory patterns during exercise Am J Respir Dis 1990;
;142: :1034–40.
109. Conrad I, Peggy S, Skaturd JB et al:et al. The Breuer- Hering reflex in humans.
Effects of pulmonary denervation and hypocapnia.: Am J Resip Crit Care Med 1995;
;152: :1747–1751.
110. Ling Z, Bernadette E, Grad DI et al:et al. Airway vascular changes in lung allograft
recipients. J Heart Lung Transplant 1999; ;18: :231–8
111. Cohen AH, Mallory GB, Ross K et al:et al. Growth of lungs after transplantation in
infants and children younger than three years of age. Am J Respir Crit Care Med
1999; ;159:1747–51.
112. Duebener LF, Takahashi Y, Wada H et al:et al. Do mature pulmonary lobes grow
after transplantation into immature recipient? Ann Thorac Surg 1999; ;68: :1165–
70.
113. Choong, CK., Sweet, SC., Bell, J et al:et al. Bronchial airway anastomotic
complications after pediatric lung transplantation: :Incidence, causes,
management and outcome. J Thorac and Cardiovasc Surg 2006; ;131:198–203.
114. Huddleston CC. Pediatric lung transplantation. Curr Treat Options Cardiovasc
Med . 2011;13:68–78. 115. Weight SS, DerHovanessian A, Wallace WD,Lynch JP and Belperido JA:
Bronchiolitis Obliterans Syndrome: The Achilles’ heel of lung transplantation.
Semin Respir Crit Care Med 2013;34:336–351.
116. Huddleston CB, Bloch JB, Sweet SC et al:et al. Lung transplantation in children.
Ann Surg 2002; ;236 (3): :270–76.
117. Date H, Yamane M, Toyooka S et al : Current status and potential of living-donor
lobar lung transplantation. Frontiers in bioscience 2008; ;13: :1433–39.
118. Kozower BD, Sweet SC, de la Morena M et al:et al. Living donor lobar grafts
improve pediatric lung retransplant survival. J Thorac Cardiovasc Surg 2006; ;131
(5):1142–47.
119. Date H. Update on living-donor lobar lung transplantation. Curr Opin Organ
Transplant 2011;16:453–7.
120. Liou TG, Adler FR, Cox DR et al:et al. Lung transplantation and survival in children
with cystic fibrosis. N Engl J Med 2007; ;357: :2143–52.